Greg Zante, VP, Finance & Administration at Sangamo Biosciences, holds 693.00 shares in Sangamo Biosciences (Ticker: SGMO), holds 149.37K shares in Viking Therapeutics (Ticker: VKTX). Most recently, Greg Zante ― shares of Sangamo Biosciences on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Greg Zante?
The percentage of profitable transactions made by Greg Zante is 0%.
What is the average return per transaction made by Greg Zante?
The average return per transaction made by Greg Zante is -144.30%.
What stocks does Greg Zante hold?
Greg Zante holds: SGMO, VKTX stocks.
What was Greg Zante’s latest transaction?
Greg Zante latest transaction was an Uninformative Buy of ―.
What was Greg Zante's most profitable transaction?
Greg Zante’s most profitable transaction was an Informative Sell of VKTX stock on July 31, 2024. The return on the trade was -20.10%.
What is Greg Zante's role in Sangamo Biosciences?
Greg Zante's role in Sangamo Biosciences is VP, Finance & Administration.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.